The prognosis for ependymoma in pediatric and adult patients is a 60 and 65 percent five-year survival rate, respectively, states the Collaborative Ependymoma Research Network Foundation. Factors affecting this prognosis include the age of the patient, location and grade of the ependymoma and the applied treatment.
Studies relating to ependymoma show that older children have better survival rates than younger children, mentions the CERN Foundation. Patients with spinal cord tumors also get better prognosis compared to those with brain tumors. When the ependymoma has advanced, the chance of survival decreases. Additionally, when the entire tumor can be removed by surgery and there's no growth of a tumor in any other part of the body, the patient's prognosis improves substantially.